Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report)'s stock price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $11.56 and last traded at $11.38, with a volume of 74269 shares traded. The stock had previously closed at $11.09.
Wall Street Analyst Weigh In
Separately, Deutsche Bank Aktiengesellschaft reissued a "buy" rating on shares of Fresenius SE & Co. KGaA in a research report on Monday, February 3rd.
Check Out Our Latest Stock Analysis on Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Trading Down 0.3 %
The firm's fifty day simple moving average is $10.64 and its 200 day simple moving average is $9.65. The stock has a market capitalization of $25.45 billion, a P/E ratio of 54.24 and a beta of 0.86. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.05 and a current ratio of 1.36.
Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.18 earnings per share for the quarter. The business had revenue of $6.01 billion during the quarter. As a group, equities research analysts forecast that Fresenius SE & Co. KGaA will post 0.79 EPS for the current fiscal year.
About Fresenius SE & Co. KGaA
(
Get Free Report)
Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
See Also
Before you consider Fresenius SE & Co. KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius SE & Co. KGaA wasn't on the list.
While Fresenius SE & Co. KGaA currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
